Phase I Trial of Temozolomide Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma
- 1 October 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (28) , 7178-7187
- https://doi.org/10.1200/jco.2005.06.502
Abstract
Purpose We conducted a two-phase clinical trial in patients with progressive malignant glioma (MG). The first phase of this trial was designed to determine the dose of O6-BG effective in producing ...Keywords
This publication has 40 references indexed in Scilit:
- A phase II study of extended low-dose temozolomide in recurrent malignant gliomasNeuro-Oncology, 2002
- Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II studyAnnals of Oncology, 2001
- Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseAnnals of Oncology, 2001
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance statusMedical Oncology, 2000
- Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First RelapseJournal of Clinical Oncology, 1999
- Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.Journal of Clinical Oncology, 1998
- Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade gliomaCancer Chemotherapy and Pharmacology, 1997
- 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activityBritish Journal of Cancer, 1996
- The basis for current treatment recommendations for malignant gliomasJournal of Neuro-Oncology, 1994